Daily non-political popular news in brief.

Drug combo improves survival in patients with COPD

A combination of inhaled salmeterol and fluticasone propionate may reduced the risk of death in patients with chronic obstructive pulmonary disease, shows new research presented at CHEST 2006, the 72nd annual international scientific assembly of the American College of Chest Physicians.

Read more »

Keywords: drug, combo, improves, survival, patients, copd, improve, patient

« Previous | Next »

Similar news on "Drug combo improves survival in patients with COPD":

1. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
2. Anthracyclines improve survival in HER2-positive breast cancer patients
   12-25-2007 · EurekAlert!
   Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
   Similar news · Read more »
   
3. Study produces conflicting findings on the use of anti-anemia drug in cancer patients
   04-16-2007 · EurekAlert!
   Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.
   Similar news · Read more »
   
4. New biomarker predicts effectiveness of breast cancer drugs
   12-07-2006 · EurekAlert!
   University of Cincinnati researchers have identified a new way to predict when anti-estrogen drug therapies are inappropriate for patients with hormone-dependent breast cancer.Scientists say these findings could help physicians more accurately predict which tumors will respond to anti-estrogen therapy and improve long-term survival for breast cancer patients.
   Similar news · Read more »
   
5. Drug improves tremors, involuntary movements in Parkinson patients
   01-01-2007 · EurekAlert!
   A drug used to treat epilepsy has been found to significantly improve tremors, motor fluctuations and other involuntary movements, or dyskinesias, in patients with Parkinson disease, according to a study published in the Jan. 2, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
6. Penn's Abramson Cancer Center part of major phase III study for myeloma
   11-21-2007 · EurekAlert!
   Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
   Similar news · Read more »
   
7. Tonsillectomy significantly improves quality of life in adult and pediatric patients
   01-01-2008 · EurekAlert!
   Tonsillectomies to treat chronic and recurrent tonsillitis substantially improve a patient's quality of live in both children and adults, according to two new studies published as a supplement to the January 2008 issue of Otolaryngology-Head and Neck Surgery.
   Similar news · Read more »
   
8. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
9. Heart failure medication does not improve survival, compared to more widely used medication
   05-01-2007 · EurekAlert!
   The drug levosimendan did not improve survival for patients with decompensated heart failure when compared with a more widely used treatment for this condition, dobutamine, according to a study in the May 2 issue of JAMA.
   Similar news · Read more »
   
10. New guidelines reinforce pulmonary rehab need for patients with COPD
    05-07-2007 · EurekAlert!
    New evidence-based guidelines from the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation recommend a comprehensive pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease, citing that pulmonary rehabilitation can help improve a patient's exercise tolerance, dyspnea and health-related quality of life, as well as decrease hospital stay and health-care utilization.
    Similar news · Read more »